| Financial Year |
March 31 2023 |
| Monetary Funds |
66,924,928.73 |
| Held-for-trading Financial Assets |
231,308,975.20 |
| Notes Receivable |
513,203.00 |
| Accounts Receivable |
140,247,602.45 |
| Advances to Suppliers |
248,593,742.79 |
| Other Receivables |
46,134,217.05 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,775,005,056.22 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
47,702,293.14 |
| Total Current Assets |
4,556,430,018.58 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
69,843,514.05 |
| Investment Properties |
213,187,695.78 |
| Fixed Assetes |
2,119,256,886.32 |
| Under-construction Projects |
215,523,596.62 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
365,886.30 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
578,794,650.71 |
| R&D expenses |
-- |
| Goodwill |
1,953,790.56 |
| Long-Term Deferred and Prepaid Expenses |
32,003,348.62 |
| Deferred Income Tax Assets |
40,241,488.15 |
| Other Non-Current Assets |
9,356,764.96 |
| Sub-Total of Non-Current Assets |
3,353,356,273.87 |
| Total Assets |
7,909,786,292.45 |
| Short-Term Loans |
1,619,428,593.05 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
367,168,085.22 |
| Accounts Received In Advance |
982,237.17 |
| Employee Compensation Payable |
250,499,280.02 |
| Taxes Payable |
78,883,319.48 |
| Interest Payable |
-- |
| Dividend Payable |
2,933,690.04 |
| Other payables |
304,157,091.99 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
17,497,883.82 |
| Other Current Liabilities |
3,672,460.14 |
| Sub-Total of Current Liabilities |
2,784,696,320.46 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
17,749,647.23 |
| Special Payable |
-- |
| Estimatied Liabilities |
3,500,000.00 |
| Deferred Income Tax Liabilities |
13,278,519.49 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
186,633,012.92 |
| Total Liabilities |
2,971,329,333.38 |
| Paid-In Capital(Or Share Stock) |
1,152,535,254.00 |
| Capital Surplus |
1,259,639,656.65 |
| Surplus Reserve |
439,624,164.67 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,016,398,959.78 |
| Minority Stockholder's Interest |
69,923,629.45 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,868,533,329.62 |
| Owner's Equity（Stockholder's Equity） |
4,938,456,959.07 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,909,786,292.45 |
